Drug intelligence / Profile preview

eseroline

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Eseroline is a small molecule alkaloid and the phenolic metabolite of physostigmine (eserine), produced by the hydrolysis of the carbamate group. Unlike its parent compound, which is a potent acetylcholinesterase inhibitor used in the treatment of glaucoma and anticholinergic toxicity, eseroline is primarily recognized for its potent analgesic activity. This effect is largely mediated through its role as an agonist at mu and delta opioid receptors, although it also retains some inhibitory activity against acetylcholinesterase. Eseroline has been extensively used in pharmacological research to investigate the structure-activity relationships of Calabar bean alkaloids and to study the dual opioid and cholinergic properties of related compounds. It is not currently used in clinical practice but remains a significant compound in neuropharmacological studies.

Other names
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-oleserol
02

Targets

AcetylcholinesteraseMOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on eseroline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eseroline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call